# Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

> **NCT02476786** · PHASE2 · RECRUITING · sponsor: **Washington University School of Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Breast Cancer
- Cancer of Breast
- Breast Neoplasms
- Cancer of the Breast

## Interventions

- **BEHAVIORAL:** FACT-B
- **DRUG:** Goserelin
- **DRUG:** Anastrozole
- **DRUG:** Exemestane
- **DRUG:** Fulvestrant
- **DRUG:** Tamoxifen
- **OTHER:** Archived tissue collection

## Key facts

- **NCT ID:** NCT02476786
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-17
- **Primary completion:** 2027-01-31
- **Final completion:** 2032-07-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476786, "Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02476786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*